Stock Market 24 February 2026

Snowflake stock price slides 4% in regular session as investors weigh AI outlook and rate fears

Snowflake stock price slides 4% in regular session as investors weigh AI outlook and rate fears

Snowflake shares fell 4.1% to $166.00 Friday, reversing gains from a post-earnings rally. The drop followed a strong forecast and record customer deal, but investors remain cautious amid doubts over AI returns and persistent inflation. Snowflake reported $1.28 billion in quarterly revenue, with product revenue up 30% year-on-year. Focus turns to customer usage trends ahead of the Snowflake Summit in June.
February 27, 2026
Ondas (ONDS) stock dips in premarket — what to watch before the opening bell

Ondas (ONDS) stock dips in premarket — what to watch before the opening bell

Ondas Inc shares fell 0.7% to $10.12 in early premarket trading Tuesday after closing at $10.19. The move comes as traders watch for follow-on orders from its counter-drone push in Europe during the Enforce Tac security fair in Nuremberg. The stock has swung sharply in February, dropping nearly 12% on Feb. 20 and trading as high as $15.28 in the past year.
February 24, 2026
Vir Biotechnology stock jumps 60%+ premarket on Astellas deal, upbeat VIR-5500 data

Vir Biotechnology stock jumps 60%+ premarket on Astellas deal, upbeat VIR-5500 data

Vir Biotechnology shares rose about 64% premarket after announcing a prostate cancer drug partnership with Astellas Pharma, bringing $335 million upfront and up to $1.37 billion in milestones. Updated Phase 1 data for VIR-5500 showed 82% of PSA-evaluable patients had at least a 50% PSA drop. Vir expects its cash to fund operations into Q2 2028. Fourth-quarter 2025 revenue reached $64.1 million, up from $12.4 million.
February 24, 2026
Arcellx stock jumps toward $115 on Gilead’s $7.8 billion buyout — what investors watch next

Arcellx stock jumps toward $115 on Gilead’s $7.8 billion buyout — what investors watch next

Arcellx shares traded near $113.75 premarket Tuesday after soaring 77% on news of Gilead’s $115-per-share cash offer. The deal includes a possible $5 per share contingent payout tied to anito-cel sales through 2029. Gilead will launch a tender offer; the FDA’s decision deadline for anito-cel is Dec. 23, 2026. The $5 payout depends on anito-cel reaching $6 billion in global sales by 2029.
February 24, 2026
Lemonade stock drops nearly 12% as LMND traders refocus on 2026 profit targets

Lemonade stock drops nearly 12% as LMND traders refocus on 2026 profit targets

Lemonade, Inc. shares dropped 11.9% Monday, closing at $50.51 after the company projected a 2026 adjusted EBITDA loss of up to $52 million. Fourth-quarter revenue rose 53% to $228.1 million, beating estimates. Short interest reached 18.3% of float as of Jan. 30. Lemonade warned it may not reach profitability and flagged risks from competition and reliance on AI.
February 24, 2026
Visa stock price today: V nudges up premarket after a 4.5% slide on AI fee fears

Visa stock price today: V nudges up premarket after a 4.5% slide on AI fee fears

Visa shares rose 0.2% to $307.09 in early premarket trading Tuesday after dropping 4.5% Monday amid a broader selloff in payment stocks. Mastercard and American Express also fell sharply in the previous session. The declines followed concerns over AI-driven disruption to card fees and ongoing legal pressure on swipe charges. Visa’s next scheduled investor events are in March.
February 24, 2026
Halma share price hits fresh 52-week high as HLMA outperforms in early London trade

Halma share price hits fresh 52-week high as HLMA outperforms in early London trade

Halma shares hit a 52-week high of 4,052 pence in early London trading Tuesday, up 1.8%, valuing the group at about £15.3 billion. No new company statement was issued, with the next update due March 12. European stocks slipped as tariff and AI concerns weighed on sentiment. Halma’s last major guidance in November projected mid-teens organic revenue growth and a 22% adjusted EBIT margin.
February 24, 2026
JTC Plc share price ticks up as big holders reshuffle in takeover “offer period”

JTC Plc share price ticks up as big holders reshuffle in takeover “offer period”

JTC shares rose 0.15% to 1,300p in early London trading Tuesday. Societe Generale cut its stake to 4.798%, while Barclays, FIL, FMR, Tudor, and Jefferies filed takeover-related disclosures. The agreed sale to Permira’s Papilio Bidco remains on track for third-quarter completion. Investors await further filings and JTC’s full-year results on April 7.
February 24, 2026
Antofagasta stock slips in early London trade even as copper jumps — what’s driving ANTO?

Antofagasta stock slips in early London trade even as copper jumps — what’s driving ANTO?

Antofagasta shares slipped 0.1% to 4,077 pence in early London trading Tuesday, despite copper prices rebounding as China’s markets reopened after the Lunar New Year. Benchmark LME copper rose 2.29% to $13,163.50 a tonne, while Shanghai futures gained 1.40%. Investors remain cautious amid rising metal inventories and uncertainty over U.S. tariffs.
February 24, 2026
Experian share price today: why EXPN stock is moving after AtData deal and a fresh buyback

Experian share price today: why EXPN stock is moving after AtData deal and a fresh buyback

Experian shares fell 0.5% to 2,511 pence in early London trading Tuesday after announcing a new tranche of share buybacks and the acquisition of AtData, an email-based identity intelligence firm. The company bought back 399,019 shares on Monday and will cancel them. Experian shares are down about 34% over the past year. Investors await full-year results in May.
February 24, 2026
BAE Systems share price ticks up as buyback rolls on — what investors watch next for LSE:BA

BAE Systems share price ticks up as buyback rolls on — what investors watch next for LSE:BA

BAE Systems shares rose 0.3% to 2,144 pence in early London trading Tuesday, recovering after a 1.3% drop Monday. The company disclosed it bought back 83,422 shares at an average price of 2,152.31 pence, bringing total repurchases in the current tranche to over 17.5 million shares. Investors focused on buybacks as sector earnings and policy signals loom.
February 24, 2026
GSK share price slides as buyback rolls on and Bora deal lands

GSK share price slides as buyback rolls on and Bora deal lands

GSK shares fell 1.1% to 2,182 pence in early London trading Tuesday after the company disclosed new share buybacks and a $250 million, five-year manufacturing contract with Bora Pharmaceuticals. GSK bought 462,000 shares Monday, bringing total repurchases since Feb. 17 to 2.229 million. Bora will manufacture more than 335 products for GSK under the deal. GSK reports first-quarter results April 29.
February 24, 2026
1 8 9 10 11 12 58